Metal Alkyl Halides
Aobchem Benzenemethanamine 3 4-dichloro-N-ethyl- hydrochloride (1 1) | ≥95% | CAS 90389-20-1 | 5g
Benzenemethanamine 3 4-dichloro-N-ethyl- hydrochloride (1 1) | ≥95% | CAS 90389-20-1 | 5g
Aobchem Benzenemethanamine 3 4-dichloro-N-ethyl- hydrochloride (1 1) | ≥95% | CAS 90389-20-1 | 250mg
Benzenemethanamine 3 4-dichloro-N-ethyl- hydrochloride (1 1) | ≥95% | CAS 90389-20-1 | 250mg
Aobchem Benzenemethanamine 3 4-dichloro-N-ethyl- hydrochloride (1 1) | ≥95% | CAS 90389-20-1 | 500mg
Benzenemethanamine 3 4-dichloro-N-ethyl- hydrochloride (1 1) | ≥95% | CAS 90389-20-1 | 500mg
Strem, An Ascensus Company CAS# 1529-48-2. 5g. Dimethylgermanium dichloride, 99%. MFCD00013588
CAS# 1529-48-2. 5g. Dimethylgermanium dichloride, 99%. MFCD00013588. Molecular Weight: 173.57. Molecular Formula: (CH3)2GeCl2. Color/form: colorless liq. Strem# 93-3202. http://www.strem.com/catalog/v/93-3202/
Pfaltz & Bauer Tributyltin chloride 97%| 100G | 1461-22-9
Tributyltin chloride 97%| 100G | 1461-22-9
ILEX LIFE SCIENCES LLC PAN Biotech CMRL 1066 Cell Culture Medium without L Glutamine without Phenol Red GMP Grade 500 ML 1/EA
PAN-Biotech CMRL 1066 Cell Culture Medium w/o L-Glutamine w/o Phenol red w 2 2 g/L NaHCO3 GMP Grade 500 ml DESCRIPTION CMRL-1066 GMP Grade is a ready-to-use chemically-defined medium designed for direct use in GMP-regulated clinical and industrial applications It provides a precisely controlled formulation that supports stable and reproducible cell culture performance Combined with high batch-to-batch consistency controlled quality parameters and comprehensive documentation CMRL-1066 GMP is a true ready-to-use medium suitable for sensitive development scale-up and manufacturing workflows QUALITY GMP Grade (EU Annex 1) BICARBONATE With 2 2 g/L Sodium Bicarbonate GLUCOSE With glucose GLUTAMINE No Glutamine HEPES Without HEPES LIQUID/POWDER Liquid PHENOL RED Without Phenol Red SODIUM PYRUVATE Without Sodium Pyruvate STERILE Yes STORAGE 2 C - 8 C MANUFACTURER PAN-Biotech GmbH COUNTRY OF ORIGIN Germany
![eMolecules 5137-55-3 | Tri-n-octylmethylammonium chloride | Chem-Impex | MFCD00011862 | 404.160 | C25H54ClN | 98.000 | [Cl-].CCCCCCCC[N+](C)(CCCCCCCC)CCCCCCCC | 100g | 112767757](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000567117.jpg-250.jpg)
eMolecules 5137-55-3 | Tri-n-octylmethylammonium chloride | Chem-Impex | MFCD00011862 | 404.160 | C25H54ClN | 98.000 | [Cl-].CCCCCCCC[N+](C)(CCCCCCCC)CCCCCCCC | 100g | 112767757
Tri-n-octylmethylammonium chloride | Chem-Impex | 5137-55-3 | MFCD00011862 | 404.160 | C25H54ClN | 98.000 | [Cl-].CCCCCCCC[N+](C)(CCCCCCCC)CCCCCCCC | 100g | 112767757
Medchemexpress LLC Tri-GalNAc-DBCO | 2999748-27-3 | 100.0% | 1730.94 | 25 MG
Tri-GalNAc-DBCO is a synthetic ligand composed of three GalNAc units connected to DBCO. It acts as a ligand for the sialic acid-degrading protein receptor (ASGPR) and can be coupled with targeting proteins or small molecules to form GalNAc-LYTACs. Tri-GalNAc-DBCO specifically binds to ASGPR and, through receptor-mediated endocytosis, guides the coupled molecules to lysosomes for degradation.
- Specifically binds to ASGPR, leading to receptor-mediated endocytosis and lysosomal degradation of coupled molecules.
- Can be conjugated with various targeting proteins or small molecules to create GalNAc-LYTACs.
- In vitro studies show it can be conjugated with anti-EGFR antibody, anti-HER2 antibody, and anti-PCSK9 antibody to form homogeneous conjugates capable of efficiently degrading membrane proteins.
- Offered at 99.97% purity.
Aobchem Benzenemethanamine 3 4-dichloro-N-ethyl- hydrochloride (1 1) | ≥95% | CAS 90389-20-1 | 1g
Benzenemethanamine 3 4-dichloro-N-ethyl- hydrochloride (1 1) | ≥95% | CAS 90389-20-1 | 1g
![Medchemexpress LLC 1-[4-(3,5-dichlorophenyl)-3-fluorophenyl]cyclopropane-1-carboxylic acid | 876625-29-5 | 99.5% | 325.16 g·mol⁻¹ | C16H11Cl2FO2 | 10 MG](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000287225.png-250.jpg)
Medchemexpress LLC 1-[4-(3,5-dichlorophenyl)-3-fluorophenyl]cyclopropane-1-carboxylic acid | 876625-29-5 | 99.5% | 325.16 g·mol⁻¹ | C16H11Cl2FO2 | 10 MG
This compound is a research-grade small-molecule inhibitor of aldo-keto reductase 1C3 (AKR1C3) that selectively blocks AKR1C3-mediated reduction of doxorubicin and can reverse doxorubicin resistance in AKR1C3-overexpressing cells. Supplied as a high-purity solid, it is intended for biochemical and cellular research applications.
- Target: AKR1C3 inhibitor.
- Mechanism: selectively blocks AKR1C3-mediated reduction of doxorubicin.
- Purity: 99.5% (reported value).
- Physical form: white to off-white solid.
- Solubility: soluble in DMSO (≈100 mg/mL); in vivo formulations reported in DMSO/corn oil.
- Storage: powder stable at -20°C for long-term storage; solutions require low-temperature storage.